Compare Manali Petrochem with Similar Stocks
Stock DNA
Petrochemicals
INR 858 Cr (Micro Cap)
13.00
13
1.01%
-0.18
4.52%
0.74
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Sep-08-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Manali Petrochemicals Ltd is Rated Sell
Manali Petrochemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 April 2026, providing investors with an up-to-date view of the company's performance and outlook.
Read full news article
Manali Petrochemicals Ltd Falls to 52-Week Low of Rs 39.52 as Sell-Off Deepens
For the second consecutive session, Manali Petrochemicals Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 39.52 on 30 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper, reflecting company-specific concerns.
Read full news article
Manali Petrochemicals Ltd Falls to 52-Week Low of Rs 41.78 as Sell-Off Deepens
For the fifth consecutive session, Manali Petrochemicals Ltd closed lower, hitting a fresh 52-week low of Rs 41.78 on 27 Mar 2026. This decline comes amid broader market weakness, but the stock’s underperformance is notably sharper than its sector peers.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
06-Apr-2026 | Source : BSEAgreement with Media Company
Announcement Under Regulation 30 Of SEBI LODR
03-Apr-2026 | Source : BSEAs per the attached Letter.
Announcement Under Regulation 30 Of SEBI LODR
02-Apr-2026 | Source : BSEAs per the attached Letter.
Corporate Actions 
No Upcoming Board Meetings
Manali Petrochemicals Ltd has declared 10% dividend, ex-date: 08 Sep 25
Manali Petrochemicals Ltd has announced 5:8 stock split, ex-date: 28 Sep 06
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 4 Schemes (0.01%)
Held by 25 FIIs (0.29%)
Sidd Life Sciences Private Limited (38.28%)
Mercantile Ventures Limited (2.39%)
39.19%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -0.41% vs 5.70% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 277.02% vs 26.57% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 2.56% vs -17.62% in Sep 2024
Growth in half year ended Sep 2025 is 145.76% vs -11.69% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 9.44% vs -14.09% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 445.81% vs 3.24% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -13.10% vs -12.30% in Mar 2024
YoY Growth in year ended Mar 2025 is 52.58% vs -62.09% in Mar 2024






